DeviceTalks Podcast Network

DeviceTalks Podcast Network

By DeviceTalks Podcast NetworkNewsHealth & FitnessTechnologyTech News
Download on the App Store

All DeviceTalks Podcast Network episodes

  • DTW – Camille Chang Gilmore shares Boston Scientific’s successful approach to hitting many DEI goals
    In this episode, Camille Chang Gilmore, vice president, human resources and global chief diversity officer, explains why she accepted Boston Scientific CEO Mike Mahoney’s offer to help lead the company’s diversity and inclusion efforts. This company’s work led to the creation of multiple programs promoting equity and combatting racism, earning Boston Scientific multiple awards and recognition from outside the company. She also shares as personal memory that speaks to the success she’s seen.
    This episode is brought to you by KNF.
    In this week’s Newmarker’s Newsmakers, Executive Editor Chris Newmarker brings a bounty of big news items from Synchron, Amazon, Intuitive, J&J and iRhythm.
    1 hr
  • Intuitive’s Conta details how the da Vinci SP (single-port) system could build a larger US Market
    In this episode of IntuitiveTalks, Jonathan Conta, vice president of product management, shares Intuitive’s vision for its da Vinci SP system, a single-port system. Rather than using four arms outside the body that require multiple ports, da Vinci SP can create triangulation inside the body. Intuitive has secured broad approval for the system in Korea, but broader US approval has been coming slowly. The company is working with surgeon customers and internal engineering teams to find the right fit for da Vinci SP. The episode is sponsored by Biomerics.
    32 min
  • Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
    In this episode, Boston Scientific CEO Michael Mahoney makes his DeviceTalks Weekly Podcast debut. In this jam-packed interview, Mahoney walks us through the cultural changes Boston Scientific has made since he joined the company a decade ago. He explains how restructuring has helped to identify leaders rather than managers. How Boston Scientific encourages people to take risks. Where does Boston Scientific see growth in markets and technologies. (We ask if Boston needs a surgical robotics platform.) Mahoney also explains how Boston Scientific knows when to let an opportunity go. We talk about experiences from his own career that others can take us lessons. Mahoney also explains what co-founder Pete Nicholas, who passed away recently, meant to the company, and what Boston Scientific will look like in five years. How will Boston Scientific move forward if the economy weakens.
    This episode is sponsored by PSN Labs.
    Executive editor Chris Newmarker brings his #NewmarkersNewsmakers – Cardinal Health, Acutus Medical, Medtronic and Boston Scientific. We also walk through a list of Medical Device companies are responding to the SCOTUS’s overturning Roe v. Wade and what this might mean for healthcare care data collection.
    1 hr 4 min
  • How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
    In this week’s episode, Cala Health CEO Renee Ryan joins us in the Newmarker’s Newsmaker’s booth to share her insights on the news of the week including an interesting meeting with Mike Mahoney before he become CEO of Boston Scientific.
    Ryan also shares details on the growing success of the Cala Trio, a device worn on the wrist to help control essential tremors. We dive deep into Cala’s story, talking with Deanna Harshbarger, vice president, product, and Doug Biehn, chief commercial officer.
    This episode is sponsored by AcuityMD.
    Executive Editor Chris Newmarker returns with his Newmarker’s Newsmakers – GE Healthcare, Boston Scientific, Ekso Bionic, Medtronic and Abbott.
    1 hr 14 min
  • Can Moon Surgical fill critical role in the OR? Analyst Matson’s take on J&J, Medtronic and more
    In this episode, Michael Matson, analyst at Needham, explains his thoughts behind a possible J&J acquisition of Boston Scientific. He also explains why he downgraded Medtronic and his take on supply chain issues. The rest of the episode will focus on Moon Surgical, which recently closed on a $31 million Series A to build a new robot that could lend critical assistance to surgeons. We speak with CEO Ann Osdoit about the company’s plans as well as investor and advisor Steve Oesterle, formerly of Medtronic. Oesterle also gives his assessment of the broader medical device-technology convergence including some fascinating forecasts for Verily. This episode is sponsored by KNF. Also hear more information about our upcoming DeviceTalks Tuesdays session and DeviceTalks West in-person meeting.
    1 hr 20 min
  • DTW - Fly into to the Data Zone! -A peak into Stryker’s playbook; What Oracle may do with Cerner
    This week listeners will get to hear how Stryker is incorporating Vocera, Gauss and other tech into its DRE strategy. We’ll get a visit from fellow podcaster Keith Figlioli of LRV Health to talk about Oracle’s acquisition of Cerner. And Chris “WorkLord” Newmarker brings a star-studded Newmarker’s Newsmakers feature Smith & Nephew, GE Healthcare, Ethicon, Medtronic, and Moon Surgical. Thank you to Flexan for sponsoring this episode! Go to Flexan.com.
    Newmarker’s Newsmakers
    5. Smith & Nephew makes historic move? https://www.massdevice.com/smithnephew-moving-out-of-hull-uk/
    4.GE Healthcare keeps making news! https://www.massdevice.com/ge-healthcare-workload-management-software-radiologists/
    3. Have you seen Ethicon's stapler? https://www.massdevice.com/ethicon-launches-next-gen-surgical-stapler/
    2. Medtronic adds more Neuromed Knowhow https://www.massdevice.com/medtronic-announces-new-chief-medical-officer-for-neuromodulation-unit/
    1. Moon launches robotic surgery bid https://www.massdevice.com/moon-surgical-raises-31m-robotic-surgery-system/
    1 hr 20 min
  • Deep look into Medtech Mergers, Investor frustration; Bonus: Medtronic moves against health inequity
    In this episode, we’ll take a deeper look into our Newmarker’s Newsmakers with Andrew Jay, general partner at the Borna Health Fund, a hedge fund that invests in medical technology companies. We’ll take about Stryker’s recent regulatory success; Quidel’s game-changing acquisition; Medtronic’s dialysis deal with DaVita and shareholder votes against executive pay at Masimo. We’ll also take a deeper look into the swirling speculation that Johnson & Johnson could look to buy Boston Scientific. In the second half of the show, we’ll run our latest MedtronicTalks podcast episode that highlighted the work the company and industry is doing to identify and combat healthcare inequity. Finally, we’ll also hear some helpful advice on cybersecurity.
    #5. https://www.massdevice.com/strykers-spine-guidance-software-fda-clearance/
    #4 https://www.massdevice.com/quidel-ortho-clinical-diagnostics-combine/
    #3 https://www.massdevice.com/medtronic-davita-kidney-device-company/
    #2 https://www.massdevice.com/masimo-no-vote-executive-pay/
    #1
    https://www.drugdeliverybusiness.com/dexcom-quashes-insulet-merger/
    https://www.massdevice.com/will-johnson-johnson-buy-boston-scientific/
    Subscribe on any major podcast channel.
    1 hr 22 min
  • Why Stryker’s Mark Paul believes we’re entering into “Golden Era” of neurovascular tech and tools
    Parenthood changes everyone, but Mark Paul’s life took a drastically different turn the moment his oldest child was born. Paul discovered he had a passion for the OR and patient treatment, a realization that convinced him to switch careers to the medical device industry. Today, Paul leads Stryker’s neurovascular business which, he says, contains the origins of the stroke treatment industry. In this interview, Paul reviews the strength and strategies of the “micro plumbers” who are helping people who are at risk of suffering a stroke or are trying to find their way back. This episode is sponsored by Resonetics.
    36 min
  • DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
    In this episode the MassDevice editorial team will break down all the action at DeviceTalks Boston. You’ll also hear from keynote speaker Eric Benjamin, executive vice president of innovation, strategy and digital products, at the company. To read MassDevice’s coverage of DeviceTalks Boston go here. https://www.massdevice.com/tag/devicetalks-boston/
    Thank you to our sponsor DeepDyve. To try out DeepDyve go to
    https://get.deepdyve.com/devicetalks/
    1 hr 27 min